Ann Dermatol.  2012 Aug;24(3):360-362. 10.5021/ad.2012.24.3.360.

Pityriasis Rosea-Like Rash Secondary to Intravesical Bacillus Calmette-Guerin Immunotherapy

• Oh CW
• Yoon J
• Kim CY

• KMID: 2265314
• DOI: http://doi.org/10.5021/ad.2012.24.3.360

Abstract

No abstract available.

MeSH Terms

Bacillus
Exanthema
Immunotherapy
Pityriasis

Figure

• 

  Fig. 1 (A) Erythematous oval macules and papules with central collarette of scales appearing shortly after the patients 2nd treatment with Bacillus Calmette-Guerin (BCG) on the trunk and (B) back. (C) A closer view of the abdominal lesion shows erythemaotus macules with a central collarette of scales.

• 

  Fig. 2 (A) Biopsy specimen of the lesion shows focal parakeratosis, acanthosis in the epidermis and superficial perivaslcular inflammatory cell infiltration in the upper dermis (H&E, ×40). (B) In high power view, the specimen shows focal parakeratosis, spongiosis, exocytosis, superficial perivascular inflammation and extravasated red blood cells (H&E, ×100).

Reference

1. Morales A. Long-term results and complications of intracavitary bacillus Calmette-Guerin therapy for bladder cancer. J Urol. 1984. 132:457–459.

2. Porena M, Del Zingaro M, Lazzeri M, Mearini L, Giannantoni A, Bini V, et al. Bacillus Calmette-Guérin versus gemcitabine for intravesical therapy in high-risk superficial bladder cancer: a randomised prospective study. Urol Int. 2010. 84:23–27.

3. Aungst CW, Sokal JE, Jager BV. Complications of BCG vaccination in neoplastic disease. Ann Intern Med. 1975. 82:666–669.

4. Honl BA, Keeling JH, Lewis CW, Thompson IM. A pityriasis rosea-like eruption secondary to bacillus Calmette-Guérin therapy for bladder cancer. Cutis. 1996. 57:447–450.

5. Kaplan B, Grunwald MH, Halevy S. Pityriasis rosea-like eruption associated with BCG vaccination. Isr J Med Sci. 1989. 25:570–572.

6. Parsons JM. Pityriasis rosea update: 1986. J Am Acad Dermatol. 1986. 15:159–167.